Ruiwen Wu - PharmaEngine Director
| 4162 Stock | TWD 90.20 2.20 2.50% |
Director
Ruiwen Wu is Director of PharmaEngine since 2018.
| Tenure | 6 years |
| Phone | 886 2 2515 8228 |
| Web | https://www.pharmaengine.com |
PharmaEngine Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. PharmaEngine's management efficiency ratios could be used to measure how well PharmaEngine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| MingChing Chen | TaiMed Biologics | N/A | |
| Howard Lee | OBI Pharma | N/A | |
| Longye Zhuo | OBI Pharma | N/A | |
| ChungMing Chang | OBI Pharma | N/A | |
| Dameng Zeng | OBI Pharma | N/A | |
| Taychang Wang | OBI Pharma | N/A | |
| Duei Tsai | TTY Biopharm Co | N/A | |
| Boxiong Lai | Medigen Biotechnology | N/A | |
| Quan Lin | TTY Biopharm Co | N/A | |
| Mingli Zhuang | Medigen Biotechnology | N/A | |
| Zhaolian Huang | TaiMed Biologics | N/A | |
| Ziliang Huang | Medigen Biotechnology | N/A | |
| ChingChow Chen | TaiMed Biologics | N/A | |
| MingLing Hsueh | TTY Biopharm Co | N/A | |
| Yougong Xu | OBI Pharma | N/A | |
| Eugene Cheng | Medigen Biotechnology | 70 | |
| Deren Liu | TaiMed Biologics | N/A | |
| Yangzong Cai | OBI Pharma | N/A | |
| LungYeh Cho | OBI Pharma | N/A | |
| TienFu Lin | TTY Biopharm Co | N/A | |
| Jerry Fong | OBI Pharma | N/A | |
Management Performance
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 |
PharmaEngine Leadership Team
Elected by the shareholders, the PharmaEngine's board of directors comprises two types of representatives: PharmaEngine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaEngine. The board's role is to monitor PharmaEngine's management team and ensure that shareholders' interests are well served. PharmaEngine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaEngine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiuji Zhang, Director | ||
| Lin C, Director | ||
| PoWu Gean, Director | ||
| Changjing Ye, CEO, General Manager, Director | ||
| HongRen Wang, Pres CEO | ||
| Yusheng Zhao, Director | ||
| LiSheng Chu, Independent Director | ||
| Fuxiu Yin, Independent Director | ||
| Guocai Pan, Director | ||
| Yuqing Su, Independent Director | ||
| ChiHsing Chang, VP Devel | ||
| Kunhong Lai, Independent Director | ||
| Chuan Lin, Director | ||
| YuFang Hu, General Manager | ||
| Bowu Jian, Director | ||
| Qiying Huang, Director | ||
| Jinrong Lin, Director | ||
| Jeffrey Suen, Chairman of the Board | ||
| Peter Wu, Director Sales | ||
| Junhui He, Chairman of the Board | ||
| Quan Lin, Director | ||
| Zhili Wang, Independent Director | ||
| C Chang, Deputy General Manager-Finance & Administration | ||
| Kangji Zhou, Independent Director | ||
| Hubert Chan, Deputy General Manager-Clinical & Regulatory Affairs | ||
| KangChi Chou, Independent Director | ||
| Melody Lin, Director HR | ||
| Lizhen Lin, Director | ||
| Li Lin, Director | ||
| Qixing Zhang, Senior Head-Finance and Administration Management | ||
| WenHwa Chang, Director | ||
| Ruiwen Wu, Director | ||
| Yihui Lin, Director | ||
| Jose Hsieh, Sr Accounting | ||
| Zhaosheng Wu, Deputy Head of Development Department | ||
| FuShiow Yin, Independent Director | ||
| Huai Wang, Independent Director | ||
| Grace Yeh, CEO, General Manager, Director | ||
| Qixiang Chen, Director | ||
| MingThau Sheu, Director | ||
| Xinyi Lin, Director |
PharmaEngine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaEngine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.53 % | |||
| Current Valuation | 14.42 B | |||
| Shares Outstanding | 143.69 M | |||
| Shares Owned By Insiders | 22.57 % | |||
| Shares Owned By Institutions | 20.72 % | |||
| Price To Book | 4.72 X | |||
| Price To Sales | 24.13 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PharmaEngine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PharmaEngine's short interest history, or implied volatility extrapolated from PharmaEngine options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PharmaEngine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for PharmaEngine Stock analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |